Selective PARP1 inhibitors, PARP1-based dual-target inhibitors, PROTAC PARP1 degraders, and prodrugs of PARP1 inhibitors for cancer therapy
Xiaopeng Peng, Wanyi Pan, Feng Jiang, Wei‐Ming Chen, Zetao Qi, Weijie Peng, Jianjun Chen
Topics & Concepts
PARP1Poly ADP ribose polymeraseProdrugSynthetic lethalityPARP inhibitorPharmacologyCancer researchMedicineDNA repairBiologyPolymeraseBiochemistryEnzymeDNAPARP inhibition in cancer therapyIntegrated Circuits and Semiconductor Failure AnalysisAdvancements in Semiconductor Devices and Circuit Design